Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-11

Clinical Trial Update: RESTIFFIC™ Foot Wrap Reduces Moderate to Severe Restless Leg Syndrome [NA]

View source ↗

Summary

A completed clinical trial indicates that RESTIFFIC Foot Wrap reduces moderate to severe Restless Leg Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RESTIFFIC Foot Wrap

Snippet

Sponsor: Lake Erie Research Institute | Conditions: Restless Leg Syndrome | NA | Status: COMPLETED